I think everyone needs to chill with the Cap Raise there might not be one. If the results are good enough towards the end of the year there might be a potential licensing deal with some money upfront to pay for the remainder of the trials it has happened in other companies is likely to happen in ours.
We all need to remember what we are, an area of unmet need orphan drug designation FastTrack designation and the FDA are supporting the company in moving forward.
Keep Buying Stop Crying!!!!
Add to My Watchlist
What is My Watchlist?
